In EOC, the levels of tenascin-C are significantly higher than in non-cancer controls (Didem et al., 2014), where a study by Wilson et al. (1996) identified that tenascin-C was significantly overexpressed in the stroma of malignant ovarian tumours when compared to benign ovarian tumours. The gene discussed is TNC; the disease is ovarian benign neoplasm.